The Scientist

» legal system and disease/medicine

Most Recent

image: How Exercise Might Fight Cancer

How Exercise Might Fight Cancer

By | September 8, 2017

Epinephrine’s activation of the signaling pathway Hippo is responsible for the in vitro tumor-fighting effects of serum from women who worked out.

0 Comments

image: Booger Bacteria’s Sweet Immune Suppression

Booger Bacteria’s Sweet Immune Suppression

By | September 6, 2017

Sweet taste receptor-activating molecules produced by sinus microbes suppress the local innate immune system in humans.

1 Comment

image: Bubbles for Broken Bones

Bubbles for Broken Bones

By | September 1, 2017

Ultrasound-stimulated microbubbles enable gene delivery to fix fractures.

0 Comments

image: Discovery of the Malaria Parasite, 1880

Discovery of the Malaria Parasite, 1880

By | September 1, 2017

Most didn’t believe French doctor Charles Louis Alphonse Laveran when he said he’d spotted the causative agent of the disease—and that it was an animal.

0 Comments

image: Far-Out Science

Far-Out Science

By | September 1, 2017

How psychedelic drugs and infectious microbes alter brain function

0 Comments

image: Decoding the Tripping Brain

Decoding the Tripping Brain

By | September 1, 2017

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

2 Comments

image: Infographic: The Brain on Psychedelics

Infographic: The Brain on Psychedelics

By | September 1, 2017

Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential.

0 Comments

The new technique helped pig tibias heal in just eight weeks.

0 Comments

image: Smoking on a Chip

Smoking on a Chip

By | September 1, 2017

A new device from the Wyss Institute at Harvard University simulates the effects of cigarette smoke on human lungs.

0 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Decoding the Tripping Brain
AAAS